Exact Mass: 294.052821
Exact Mass Matches: 294.052821
Found 491 metabolites which its exact mass value is equals to given mass value 294.052821,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Estazolam
Estazolam is only found in individuals that have used or taken this drug. It is a benzodiazepine with anticonvulsant, hypnotic, and muscle relaxant properties. It has been shown in some cases to be more potent than diazepam or nitrazepam. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Tuliposide B
Tuliposide b is a member of the class of compounds known as hexoses. Hexoses are monosaccharides in which the sugar unit is a is a six-carbon containing moeity. Tuliposide b is soluble (in water) and a very weakly acidic compound (based on its pKa). Tuliposide b can be found in garden onion, which makes tuliposide b a potential biomarker for the consumption of this food product.
(3S,4R)-3,4,5-trihydroxy-8-oxospiro[6,7-dihydronaphthalene-5,2-oxolane]-2-carboxylic acid
Aplysin
C15H19BrO (294.06191839999997)
Filiformin
C15H19BrO (294.06191839999997)
Laurinterol
C15H19BrO (294.06191839999997)
A sesquiterpenoid isolated from Laurencia intermedia and Aplysia kurodai and has been found to exhibit antibacterial activity,
Cyanthoate
C10H19N2O4PS (294.08031040000003)
6-tuliposide B
A 6-O-acyl-D-glucose in which the 6-acyl group is specified as (3S)-3,4-dihydroxy-2-methylidenebutanoyl. A secondary metabolite with potent antibacterial activity, occurring specifically in tulip anthers.
Tyrphostin B42
C17H14N2O3 (294.10043740000003)
D000970 - Antineoplastic Agents > D020032 - Tyrphostins D004791 - Enzyme Inhibitors
Methoxybrassenin B
C13H14N2O2S2 (294.04966640000004)
Methoxybrassenin B is found in brassicas. Methoxybrassenin B is a stress metabolite isolated from cabbage inoculated with Pseudomonas cichorii. Stress metabolite isolated from cabbage inoculated with Pseudomonas cichorii. Methoxybrassenin B is found in brassicas.
Glyzarin
Glyzarin is found in herbs and spices. Glyzarin is a constituent of Glycyrrhiza glabra (licorice)
Wasalexin A
C13H14N2O2S2 (294.04966640000004)
Wasalexin A is found in brassicas. Wasalexin A is a constituent of Wasabia japonica (Japanese horseradish) Constituent of Wasabia japonica (Japanese horseradish). Wasalexin A is found in brassicas and wasabi.
7-Acetoxy-2-methylisoflavone
7-Acetoxy-2-methylisoflavone is found in herbs and spices. 7-Acetoxy-2-methylisoflavone is isolated from Glycyrrhiza glabra (licorice
gamma-L-Glutamyl-L-methionine sulfoxide
gamma-L-Glutamyl-DL-methionine sulfoxide is found in nuts. gamma-L-Glutamyl-DL-methionine sulfoxide is isolated from the seeds of Fagus silvatica (beechnuts). Isolated from the seeds of mung bean (Vigna radiata) and black gram (Vigna mungo). gamma-L-Glutamyl-L-methionine sulfoxide is found in pulses.
Rosoxacin
C17H14N2O3 (294.10043740000003)
Rosoxacin is a quinolone derivative antibiotic for the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients. Rosoxacin is known to be effective against penicillin resistant strains and is a single dose orally administered drug, which avoids all complications of parenteral administration seen with penicillin, especially anaphylactic shock. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents
Sulfacytine
Sulfacytine is a short-acting sulfonamide. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Sulfacytine is a competitive inhibitor of the enzyme dihydropteroate synthetase. It inhibits bacterial synthesis of of dihydrofolic acid by preventing the condensation of the pteridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
3-Methoxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one
3-Methoxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one is found in fruits. 3-Methoxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one is a constituent of the roots of Mangifera indica (mango)
Wasalexin B
C13H14N2O2S2 (294.04966640000004)
Wasalexin B is found in brassicas. Wasalexin B is a constituent of Wasabia japonica (Japanese horseradish) Constituent of Wasabia japonica (Japanese horseradish). Wasalexin B is found in brassicas and wasabi.
4-[(2,4-Dihydroxyphenyl)azo]benzenesulfonic acid
4-[(2,4-Dihydroxyphenyl)azo]benzenesulfonic acid is a food dye; no longer permitted in the EU. Food dye; no longer permitted in the EU
Tyrphostin B42
C17H14N2O3 (294.10043740000003)
6-Hydroxymethylsulfadimidine
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
Benzenesulfonamide, 4-amino-N-(5-hydroxy-4,6-dimethyl-2-pyrimidinyl)-
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
Lanceolatin C
Pongamol (Lanceolatin C) is potent α-glucosidase inhibitor (IC50=103.5 μM) and has free-radical (DPPH) scavenging,antihyperglycemic, and antihyperglycemic activities[1].
3,4-Bis(carboxymethyl)-3,4-dihydroxyhexanedioic acid
C10H14O10 (294.05869440000004)
Sulfametomidine
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
N~4~-Cyclopropyl-6-(2,3-Dichlorophenyl)pyrimidine-2,4-Diamine
15-Bromo-1,3(15),7-chamigratrien-9-one
C15H19BrO (294.06191839999997)
Cupalaurenol
C15H19BrO (294.06191839999997)
Isolaurenisol
C15H19BrO (294.06191839999997)
Isoaplysin
C15H19BrO (294.06191839999997)
Allolaurinterol
C15H19BrO (294.06191839999997)
Neolaurinterol
C15H19BrO (294.06191839999997)
2-[3-(bromomethylene)-1,2-dimethylcyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
Cyclolaurenol
C15H19BrO (294.06191839999997)
(+)-2-(Bromomethyl)-2,3,4,5-tetrahydro-5,8,10-trimethyl-2,5-methano-1-benzoxepin
C15H19BrO (294.06191839999997)
Isolaurinterol
C15H19BrO (294.06191839999997)
pongamol
Pongamol (Lanceolatin C) is potent α-glucosidase inhibitor (IC50=103.5 μM) and has free-radical (DPPH) scavenging,antihyperglycemic, and antihyperglycemic activities[1].
Mesulfenfos
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3707 CONFIDENCE standard compound; INTERNAL_ID 3014
2-Anilino-6-oxo-4-(2-thienyl)-1,6-dihydropyrimidine-5-carbonitrile
C15H10N4OS (294.05752900000005)
OCP_295.0845_17.0
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1303
hydroxymethylenetanshinquinone
1,2-Methylendioxy-6-nitroso-6abeta-aporphan|1,2-methylenedioxy-6-nitroso-6abeta-aporphane|5H-benzo[g]-1,3-benzodioxolo[5,6,4]quinoline-6,7,7a,8-tetrahydro-7-nitroso-(7aR)|N-nitrosoanonaine
C17H14N2O3 (294.10043740000003)
9,10-Anthracenedione, 2-acetyl-1-hydroxy-3,6-dimethyl-
4-Hydroxy-6-(4-hydroxyphenyl)-5H-furo[3,2-g][1]benzopyran-5-one
(2S,3S)-3-O-caffeyl-2,3,4-trihydroxy-2-methylbutan-1,4-olide|3-O-Caffeoyl-2-C-methyl-D-erythrono-1,4-lactone
1,2-Dihydro-1,6-dimethyl-3,11-dioxanaphth[2,1-e]azulene-10,12-dione
9-hydroxy-2-isopropenyl-1,8-dioxa-dicyclopenta[b,g]naphthalene-4,10-dione
1-Hydroxy-2-acetyl-3,7-dimethyl-9,10-anthraquinone
2-(4,5,5-Trimethyl-1-cyclopentenyl)-4-bromo-5-methylphenol
C15H19BrO (294.06191839999997)
1,3-Propanedione, 1-(4-methoxy-5-benzofuranyl)-3-phenyl-
amabiose|beta-D-glucopyranosyl(1->5)beta-D-hemslofuranosyl(1->2)
3-O-beta-D-glucopyranosyl-2-deoxy-D-ribono-gamma-lactone
9-((Z)-bromomethylidene)-1,2,5-trimethylspiro<5.5>undeca-1,7-dien-3-one|9-((Z)-bromomethylidene)-1,2,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)
3,4-(Methylenedioxy)-8-methoxy-10-hydroxyphenanthrene-1-carboxylic acid lactone
3,4-Dihydroxy-5-(2,3,4-trihydroxyphenoxy)benzoic acid
(3Z,6Z,9Z)-13-bromo-5,12-epoxypentadeca-3,6,9-trien-1-yne
C15H19BrO (294.06191839999997)
{(Z)-3-(chloromethylene)-2,3-dihydrobenzo[b]oxepin-7-yl}methyl trimethysilyl ether
C15H19ClO2Si (294.08427839999996)
(3Z,6Z,9Z)-12-bromo-5,13-epoxypentadeca-3,6,9-trien-1-yne
C15H19BrO (294.06191839999997)
3-methyl-8,9-methylenedioxycoumestone|flemmichapparin C
AG-490
C17H14N2O3 (294.10043740000003)
3-(6,8-dimethoxy-1-oxoisochromen-3-yl)-2-hydroxypropanoic acid
2-(2-hydroxyphenyl)-4-phenylbenzene-1,3,5-triol
C17H14N2O3_(3S,3R)-4-Methyl-3-phenylspiro[1,4-benzodiazepine-3,2-oxirane]-2,5(1H,4H)-dione
C17H14N2O3 (294.10043740000003)
estazolam
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
(4R,5S or 4S,5R)-4-hydroxy-5-((?-D-glucopyranosyloxy)methyl)dihydrofuran-2(3H)-one
2-Butanone, 4-[6-(sulfooxy)-2-naphthalenyl]-
C14H14O5S (294.05619140000005)
rosoxacin
C17H14N2O3 (294.10043740000003)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents
Sulfacytine
C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
Wasalexin A
C13H14N2O2S2 (294.04966640000004)
Wasalexin B
C13H14N2O2S2 (294.04966640000004)
g-L-Glutamyl-L-methionine sulfoxide
Methoxybrassenin B
C13H14N2O2S2 (294.04966640000004)
1-O-(3R,4-dihydroxy-2-methylene-butanoyl)-beta-D-glucopyranose
6-O-(3R,4-dihydroxy-2-methylene-butanoyl)-beta-D-glucopyranose
1,1,1-Trifluoro-N-(1,2,3,4-tetrahydro-1-methyl-7-quinolinyl)-methanesulfonamide
2-n-boc-amino-4-benzothiazole-6-carboxylic acid
C13H14N2O4S (294.06742440000005)
N-(5-Bromopyrazin-2-yl)-2-amino-4-methoxyaniline
C11H11BrN4O (294.01161759999997)
N-[4-chloro-2-(trifluoromethyl)phenyl]-2-propoxyethanimidamide
C12H14ClF3N2O (294.07466999999997)
Metalol hydrochloride
C11H19ClN2O3S (294.08048540000004)
3-[(2-CHLORO-6-FLUOROBENZYL)OXY]-4-METHOXYBENZALDEHYDE
C15H12ClFO3 (294.04589639999995)
3-[(2-CHLORO-4-FLUOROBENZYL)OXY]-4-METHOXYBENZALDEHYDE
C15H12ClFO3 (294.04589639999995)
1-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-3,5-DIMETHYL-1H-PYRAZOLEHYDROBROMIDE
n,n-bis(2-hydroxyethyl)-4-phenylenediamine sulphate
3-amino-4-chloro-N-(5-chloro-2-methylphenyl)benzamide
methyl 2-[(2-chloroacetyl)amino]-3-(1h-indol-3-yl)propanoate
2-tert-Butoxycarbonylamino-benzothiazole-4-carboxylic acid
C13H14N2O4S (294.06742440000005)
5-(4-(Benzyloxy)phenyl)-1H-pyrazole-3-carboxylic acid
C17H14N2O3 (294.10043740000003)
10-CHLORO-2,3,4,6,7,11B-HEXAHYDRO-1H-PYRAZINO[2,1-A]ISOQUINOLINE DIHYDROCHLORIDE
C12H17Cl3N2 (294.04572520000005)
3-AMINO-3-[5-(3-CHLORO-4-METHOXYPHENYL)-FURAN-2-YL]-PROPIONIC ACID AMIDE
2-[(2-CHLORO-6-FLUOROBENZYL)OXY]-3-METHOXYBENZALDEHYDE
C15H12ClFO3 (294.04589639999995)
2-[(2-chloro-4-fluorophenyl)methoxy]-3-methoxybenzaldehyde
C15H12ClFO3 (294.04589639999995)
N,N-Bis(2-hydroxyethyl)-p-phenylenediamine sulphate
4-FORMYL-5-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID
Ethyl 1-tosyl-1H-imidazole-4-carboxylate
C13H14N2O4S (294.06742440000005)
1-[(4-NITROBENZYLOXY)CARBONYL]-PYRROLIDINE-2-CARBOXYLIC ACID
(2-FLUORO-PHENYLAMINO)-ACETICACIDHYDRAZIDE
C17H14N2O3 (294.10043740000003)
1,1,1-Trifluoro-2-trifluoromethyl-2-hydroxy-4-pentyl methacrylate
2-(N-CARBOXYMETHYL-N-PHENYL)AMINO-4,6-DIMERCAPTO-1,3,5-TRIAZINE
2-Amino-3-phthalimid-1-ylpropiophenone
C17H14N2O3 (294.10043740000003)
CYCLOHEPTA[B]PYRAN-4,9-DIONE, 2-(1,3-BENZODIOXOL-5-YL)-
Bucloxic acid
C16H19ClO3 (294.10226539999996)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents
Cliprofen
C14H11ClO3S (294.01174060000005)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
N-(3-amino-4-methylphenyl)-3-(trifluoromethyl)benzamide
p-(t-butyl)phenethyltrichlorosilane
C12H17Cl3Si (294.01650520000004)
4-[(2-chloro-6-fluorobenzyl)oxy]-3-methoxybenzaldehyde
C15H12ClFO3 (294.04589639999995)
2-(4-isothiocyanatophenyl)-N,N-dimethyl-1-benzofuran-6-amine,hydrochloride
Ethyl 2-(pyrrolidin-1-yl)-4-trifluoromethyl-1,3-thiazole-5-carboxylate
6-chloro-N-(oxan-4-ylmethyl)-5-(trifluoromethyl)pyridin-2-amine
C12H14ClF3N2O (294.07466999999997)
4-amino-3-methyl-N-[3-(trifluoromethyl)phenyl]benzamide
6-METHOXY-3-[4-(TRIFLUOROMETHYL)PHENYL][1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE
2-[hydroxy(2-prop-2-enoyloxyethoxy)phosphoryl]oxyethyl prop-2-enoate
4-(AMINOMETHYL)-2-(4-TRIFLUOROMETHYL)PHENYL-1,3-THIAZOLE HYDROCHLORIDE 95{2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-4-YL}METHYLAMINE HYDROCHLORIDE
C11H10ClF3N2S (294.02052860000003)
(Z)-4-(4-Nitrobenzylidene)-2-phenyloxazol-5(4H)-one
(Z)-4-(2-Nitrobenzylidene)-2-phenyloxazol-5(4H)-one
5-OXO-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL TRIFLUOROMETHANESULFONATE
C11H9F3O4S (294.01736300000005)
4-[6-Chloro-2-(trifluoromethyl)-4-pyrimidinyl]-1-piperazinecarbal dehyde
Sulfaethoxypyridazine
D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
3-amino-4-chloro-N-(4-chloro-3-methylphenyl)benzamide
4-Chloro-7-(3-chloropropoxy)-6-methyl-3-quinolinecarbonitrile
6-CHLORO-9A-(2-FLUOROETHYL)-7-METHOXY-9,9A-DIHYDRO-1H-FLUOREN-3(2H)-ONE
6-chloro-N-[(4-methoxyphenyl)methyl]-5-nitropyrimidin-4-amine
6-(Dibutylamino)-1,3,5-triazine-2,4-dithiol·sodium
Lofexidine hydrochloride
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Lofexidine (hydrochloride) is a selective α2-receptor agonist, commonly used to alleviate the physical symptoms of heroin and other types of opioid withdrawal[1][2].
4-(6-METHOXY-BENZOTHIAZOL-2-YLCARBAMOYL)-BUTYRIC ACID
C13H14N2O4S (294.06742440000005)
6-N-Benzyl-2-chloro-5,6,7,8-tetrahydro-1,6-naphthyridine HCl
1-BENZYL-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDIN-4-YL ACETATE
C17H14N2O3 (294.10043740000003)
(E)-2-(4-bromophenyl)-3-cyclohexylprop-2-en-1-ol
C15H19BrO (294.06191839999997)
4,4,4-trifluoro-3-hydroxy-3-(4-phenylphenyl)butan-2-one
2-(2,2,3,3,4,4,4-heptafluorobutanoyl)cyclohexan-1-one
(z)-3,4-dihydro-3-(2-(4-methoxyphenyl)-2-oxoethylidene)quinoxalin-2(1h)-one
C17H14N2O3 (294.10043740000003)
2-oxo-2-(5-phenylmethoxy-1H-indol-3-yl)acetamide
C17H14N2O3 (294.10043740000003)
8-chloro-9a-(2-fluoroethyl)-7-methoxy-2,9-dihydro-1H-fluoren-3-on e
(1S,4S)-(+)-2-(3-CHLORO-BENZYL)-2,5-DIAZA-BICYCLO[2.2.1]HEPTANE DIHYDROCHLORIDE
C12H17Cl3N2 (294.04572520000005)
4-[(2-CHLORO-4-FLUOROBENZYL)OXY]-3-METHOXYBENZALDEHYDE
C15H12ClFO3 (294.04589639999995)
2-(4-METHOXY-PHENYL)-5-PHENYL-2H-PYRAZOLE-3-CARBOXYLIC ACID
C17H14N2O3 (294.10043740000003)
Nuclomedone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Aluminum Lactate
C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
1-FURFURYL-3-(P-TOLYLSULFONYL)-UREA
C13H14N2O4S (294.06742440000005)
1-(4-METHOXYPHENYL)-5-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID
C17H14N2O3 (294.10043740000003)
2-(2-CHLOROBENZYL)-2,5-DIAZABICYCLO[2.2.1]HEPTANE
C12H17Cl3N2 (294.04572520000005)
(6E)-6-[(2-chloro-6-fluorophenyl)methylidene]-7H-[1,3]thiazolo[3,2-a]pyrimidin-5-one
6-[(2-chloro-6-fluorophenyl)methyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one
2-[(Benzyloxy)methyl]-1-bromo-4-fluorobenzene
C14H12BrFO (294.00554939999995)
7-Nitrobenzoxadiazole-6-aminohexanoic acid
4-(4-Chloro-phenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid ethyl ester
2-(4-methoxyphenyl)imino-3-methyl-4-oxo-1,3-thiazinane-6-carboxylic acid
C13H14N2O4S (294.06742440000005)
(2S,3R,4S,5S)-5-(chloromethyl)tetrahydrofuran-2,3,4-triyl triacetate
C11H15ClO7 (294.05062699999996)
(6-BROMOHEXYLOXY)-TERT-BUTYLDIMETHYL-
C12H27BrOSi (294.10144319999995)
(NZ)-N-[3-[(2-chloro-1,3-thiazol-5-yl)methyl]-5-(trideuteriomethyl)-1,3,5-oxadiazinan-4-ylidene]nitramide
4-ACETYL-[1,1-BIPHENYL]-4-SULFONYL CHLORIDE
C14H11ClO3S (294.01174060000005)
1H-Indole-3-carboxaldehyde,2-methyl-1-[(2-nitrophenyl)methyl]-(9CI)
C17H14N2O3 (294.10043740000003)
2-[2-(3,4-dimethoxyanilino)-1,3-thiazol-4-yl]acetic acid
C13H14N2O4S (294.06742440000005)
1H-Indole,3-(2-nitroethenyl)-5-(phenylmethoxy)-
C17H14N2O3 (294.10043740000003)
3-cyano-4-trifluoromethyl-6-(4-methoxyphenyl)-pyridine-2-one
methyl 2-[1-(4-methylphenyl)sulfonylimidazol-4-yl]acetate
C13H14N2O4S (294.06742440000005)
4,4,5,5-TETRAMETHYL-2-(PERFLUOROPHENYL)-1,3,2-DIOXABOROLANE
C12H12BF5O2 (294.08504619999997)
5-(4-chlorophenyl)-2-(1,3-dioxolan-2-yl)-3-furoic acid
5-AMINO-1-CYCLOPROPYL-6,7-DIFLUORO-1,4-DIHYDRO-8-METHYL-4-OXO-3-QUINOLINECARBOCYLIC ACID
9-chloro-2,3,4,6,7,11b-hexahydro-1H-pyrazino[2,1-a]isoquinoline,dihydrochloride
C12H17Cl3N2 (294.04572520000005)
2,4-dichloro-N-(4-methoxyphenyl)benzenecarboximidamide
1H-Indole-3-carboxaldehyde,2-methyl-1-[(3-nitrophenyl)methyl]-(9CI)
C17H14N2O3 (294.10043740000003)
N~4~-Cyclopropyl-6-(2,3-Dichlorophenyl)pyrimidine-2,4-Diamine
Solaraze
C14H10Cl2NO2- (294.00885600000004)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Phccc
C17H14N2O3 (294.10043740000003)
PHCCC is a Group I mGluR antagonist with an IC50 of 3 μM. PHCCC is a selective positive modulator of mGlu4 receptor. Antiparkinsonian effect[1][2].
5-(piperidin-1-ylsulfonyl)-1H-indole-2,3-dione
C13H14N2O4S (294.06742440000005)
N4-(3-chlorophenyl)-N2-methyl-5-nitropyrimidine-2,4,6-triamine
C11H11ClN6O2 (294.06319759999997)
2-[(1-Acetyl-1H-indol-3-YL)amino]benzoic acid
C17H14N2O3 (294.10043740000003)
N5-(2,4-dichlorophenyl)pyrazolo[3,4-d]pyrimidine-4,5-diamine
3-[3-(5-methylfuran-2-yl)-1-phenyl-1H-pyrazol-4-yl]prop-2-enoic acid
C17H14N2O3 (294.10043740000003)
7-Methoxy-2-phenylimino-1-benzopyran-3-carboxamide
C17H14N2O3 (294.10043740000003)
5-Methyl-alpha-((5-nitro-2-furanyl)methylene)-1H-benzimidazole-2-acetonitrile
5-[(3-methyl-2-thienyl)methylene]-2-(4-morpholinyl)-1,3-thiazol-4(5H)-one
C13H14N2O2S2 (294.04966640000004)
4-Methyl-alpha-((5-nitro-2-furanyl)methylene)-1H-benzimidazole-2-acetonitrile
(2E)-4-(4-(2-Chlorophenyl)-1-piperazinyl)-4-oxo-2-butenoic acid
4-Chloro-6-(4-piperazin-1-YL-1H-pyrazol-5-YL)benzene-1,3-diol
1-((2-Hydroxyethoxy)methyl)-5-(phenylthio)pyrimidine-2,4(1H,3H)-dione
C13H14N2O4S (294.06742440000005)
(3r)-4,4-Difluoro-3-[(4-Methoxyphenyl)sulfonyl]butanoic Acid
C11H12F2O5S (294.03734860000003)
5-amino-1-(5-phosphonato-beta-D-ribosyl)imidazol-3-ium
C8H13N3O7P- (294.04910980000005)
An organophosphate oxoanion obtained by deprotonation of the phosphate OH groups as well as protonation of the endocyclic nitrogen at position 3 in the imidazole ring of 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
5-methyl-N-(4-nitrophenyl)-1,1-dioxo-1lambda6-thiophene-2-carboxamide
(3S,4S,4aR,5R,6R,7R,7aS)-5,6-bis(hydroxymethyl)spiro[4a,6,7,7a-tetrahydro-3H-furo[2,3-b][1,4]dioxine-2,2-oxolane]-3,4,7-triol
(E/Z)-AG490
C17H14N2O3 (294.10043740000003)
4-Amino-5-(2-amino-4-methylsulfanylbutanoyl)peroxy-5-oxopentanoic acid
2-[(2,6-Dichloro-3-methylphenyl)amino]benzoate
C14H10Cl2NO2- (294.00885600000004)
3-Chloro-4-(dimethylamino)-6-(4-nitrophenyl)-2-pyranone
5-amino-1-(5-phosphonato-D-ribosyl)imidazol-3-ium
C8H13N3O7P- (294.04910980000005)
Conjugate base of 5-amino-1-(5-phospho-D-ribosyl)imidazole. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3-(9-carbazolylmethyl)-4-methyl-1H-1,2,4-triazole-5-thione
3-(4-chlorophenyl)-5-(4,5-dihydro-1H-imidazol-2-ylsulfanylmethyl)-1,2,4-oxadiazole
3-phenyl-2-sulfanylidene-1H-benzofuro[3,2-d]pyrimidin-4-one
C16H10N2O2S (294.04629600000004)
1-(3-Chloro-4-methoxyphenyl)-3-(2-fluorophenyl)urea
C14H12ClFN2O2 (294.05712939999995)
N-(3-acetylphenyl)-3,5-dimethyl-4-isoxazolesulfonamide
C13H14N2O4S (294.06742440000005)
2-[(2,5-Dimethyl-3-phenyl-7-pyrazolo[1,5-a]pyrimidinyl)thio]acetonitrile
(5Z)-2-(benzylamino)-5-benzylidene-1,3-thiazol-4-one
3-[(2,5,6-Trimethyl-4-thieno[2,3-d]pyrimidinyl)thio]-2-oxolanone
C13H14N2O2S2 (294.04966640000004)
2-(2-methoxyethylthio)-N-(2-thiazolyl)benzamide
C13H14N2O2S2 (294.04966640000004)
3-Chloro-1-(2,4-dimethylphenyl)-4-(2-hydroxyethylamino)pyrrole-2,5-dione
2-[1-(2-Methylphenyl)-3-oxo-3-thiophen-2-ylpropyl]propanedinitrile
2-[5-(Anilinomethylidene)-4-oxo-2-sulfanylidene-3-thiazolidinyl]acetic acid
2-Bromo-6,7,8,9,10,12-hexahydroazepino[2,1-b]quinazolin-12-ol
N4-(4-Chlorophenyl)-N2-methyl-5-nitropyrimidine-2,4,6-triamine
C11H11ClN6O2 (294.06319759999997)
Carbonyl(eta(5)-cyclopentadienyl)(1,3-dimethylimidazolidin-2-ylidene)rhodium
6-(1-Carboxy-2-methoxy-2-oxoethyl)-3,4,5-trihydroxyoxane-2-carboxylic acid
C10H14O10 (294.05869440000004)
(Z)-3-(3-Chloro-4-hydroxy-5-methoxyphenyl)-2-cyano-N-propan-2-ylprop-2-enamide
3,4,5-Trihydroxy-6-(3-methoxy-3-oxopropanoyl)oxyoxane-2-carboxylic acid
C10H14O10 (294.05869440000004)
(4R,5S)-4-hydroxy-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxolan-2-one
3-(6,8-Dimethoxy-1-oxoisochromen-3-yl)-2-hydroxypropanoic acid
Sulfametomidine
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01E - Sulfonamides and trimethoprim > J01ED - Long-acting sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
3-Methoxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one
SIRT1-IN-3
SIRT1-IN-3 (compound 3j) is a potent and selective SIRT1 inhibitor, with an IC50 of 4.2 μM[1].
4-hydroxy-4-methyl-5-oxooxolan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
16-hydroxy-5-(prop-1-en-2-yl)-4,14-dioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(9),3(7),5,10,12,15-hexaene-2,8-dione
4-bromo-2-[(1s,3r)-1,3-dimethyl-2-methylidenecyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
2-(1-bromopropyl)-9-(but-1-en-3-yn-1-yl)-2,3,6,9-tetrahydrooxonine
C15H19BrO (294.06191839999997)
3-[5-carboxy-4-(carboxymethyl)pyrrolidin-3-yl]pyridine-2-carboxylic acid
(2r,3r,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexyl (3s)-3,4-dihydroxy-2-methylidenebutanoate
2-[(1e)-2-methanesulfinylethenyl]-7,8-dimethoxychromen-4-one
C14H14O5S (294.05619140000005)
1,4-dihydroxy-2,5,5-trimethyl-9-thiatetracyclo[6.5.0.0²,¹¹.0³,⁷]tridec-3(7)-ene-6,12-dione
4-bromo-2-[(1r,3s)-1,3-dimethyl-2-methylidenecyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
(12s)-7-methoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-10-one
4-bromo-1,5,9,12-tetramethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-triene
C15H19BrO (294.06191839999997)
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3s)-3,4-dihydroxy-2-methylidenebutanoate
(6r,9e)-9-(bromomethylidene)-1,5,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)
(4r)-4-benzyl-4-methoxy-3,10-dioxatricyclo[7.3.0.0²,⁶]dodeca-1,6,8,11-tetraen-5-one
{[3-(chloromethylidene)-2h-1-benzoxepin-7-yl]methoxy}trimethylsilane
C15H19ClO2Si (294.08427839999996)
(?)-(2s)-6-methoxy-[2'',3'':7,8]-furanoflavanone
{"Ingredient_id": "HBIN006775","Ingredient_name": "(?)-(2s)-6-methoxy-[2'',3'':7,8]-furanoflavanone","Alias": "NA","Ingredient_formula": "C18H14O4","Ingredient_Smile": "COC1=C2C(=C3C(=C1)C(=O)CC(O3)C4=CC=CC=C4)C=CO2","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13927","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-β-hydroxymethylenetanshiquinone
{"Ingredient_id": "HBIN008250","Ingredient_name": "3-\u03b2-hydroxymethylenetanshiquinone","Alias": "NA","Ingredient_formula": "C18H14O4","Ingredient_Smile": "CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCC(C4=C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15888","TCMID_id": "10491","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-beta-Hydroxymethyllenetanshiquinone
{"Ingredient_id": "HBIN008251","Ingredient_name": "3-beta-Hydroxymethyllenetanshiquinone","Alias": "(7S)-7-hydroxy-1-methyl-6-methylene-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-quinone; (7S)-7-hydroxy-1-methyl-6-methylidene-8,9-dihydro-7H-naphtho[8,7-g][1]benzoxole-10,11-dione; (7S)-7-hydroxy-1-methyl-6-methylene-8,9-dihydro-7H-naphtho[8,7-g]benzofuran-10,11-dione; 3-beta-hydroxymethyllenetanshiquinone","Ingredient_formula": "C18H14O4","Ingredient_Smile": "Not Available","Ingredient_weight": "294.32","OB_score": "32.16103376","CAS_id": "NA","SymMap_id": "SMIT00958","TCMID_id": "31235","TCMSP_id": "MOL007059","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
aristololide
{"Ingredient_id": "HBIN016823","Ingredient_name": "aristololide","Alias": "NA","Ingredient_formula": "C17H10O5","Ingredient_Smile": "NA","Ingredient_weight": "294.26","OB_score": "NA","CAS_id": "86030-64-0","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6656","PubChem_id": "NA","DrugBank_id": "NA"}
5-hydroxy-6-methyl-4-oxo-5,6-dihydropyran-3-yl 2,4-dihydroxy-6-methylbenzoate
9-(bromomethyl)-1,5,12-trimethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene
C15H19BrO (294.06191839999997)
6-({2-oxo-3h,3ah,4h,7ah-furo[2,3-b]pyran-4-yl}oxy)-3h,3ah,6h,7ah-furo[2,3-b]pyran-2-one
(2s,5s,6s)-6-(bromomethyl)-2,5,10-trimethyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene
C15H19BrO (294.06191839999997)
(1r,9s)-4-bromo-1,5,12,12-tetramethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-triene
C15H19BrO (294.06191839999997)
13,13,15-trimethyl-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-1,3,5,7,10,15-hexaene-12,14-dione
(3s)-3-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-4-methoxy-4-oxobutanoic acid
(1s,2r,4s,8s,11r)-1,4-dihydroxy-2,5,5-trimethyl-9-thiatetracyclo[6.5.0.0²,¹¹.0³,⁷]tridec-3(7)-ene-6,12-dione
(1r,13r)-17-methoxy-7,11,20-trioxapentacyclo[11.7.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-2(10),3,5,8,14,16,18-heptaene
5-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-one
(4s,5r)-5-(hydroxymethyl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-2-one
16-methyl-5,7,11,19-tetraoxapentacyclo[10.8.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]icosa-1(12),2(10),3,8,13(18),14,16-heptaen-20-one
(1s,8r,10r,11r)-1,6,11-trihydroxy-4-imino-10-methyl-3-oxo-9-oxatricyclo[6.2.2.0²,⁷]dodeca-2(7),5-diene-5-carboximidic acid
5,11-dihydroxy-2-methylindeno[5,6-h]chromene-4,10-dione
(3as,6s,7as)-6-{[(3as,4r,7as)-2-oxo-3h,3ah,4h,7ah-furo[2,3-b]pyran-4-yl]oxy}-3h,3ah,6h,7ah-furo[2,3-b]pyran-2-one
4-bromo-2-(1,3-dimethyl-2-methylidenecyclopentyl)-5-methylphenol
C15H19BrO (294.06191839999997)
(6s,9z)-9-(bromomethylidene)-1,5,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)
(7s)-7-hydroxy-1-methyl-6-methylidene-7h,8h,9h-phenanthro[1,2-b]furan-10,11-dione
2-[(1r,2r,3e)-3-(bromomethylidene)-1,2-dimethylcyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
(2s,5s,6s)-11-bromo-2,5,6,10-tetramethyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(8),9,11-triene
C15H19BrO (294.06191839999997)
{[(3z)-3-(chloromethylidene)-2h-1-benzoxepin-7-yl]methoxy}trimethylsilane
C15H19ClO2Si (294.08427839999996)
8-(2-chloro-1-hydroxy-3-methylbut-3-en-1-yl)-7-methoxychromen-2-one
4-bromo-2-methyl-5-(1,2,2-trimethylcyclopent-3-en-1-yl)phenol
C15H19BrO (294.06191839999997)
(2e)-3-phenylprop-2-enoyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(3s)-3-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-4-methoxy-4-oxobutanoic acid
14-methoxy-3,5,10-trioxapentacyclo[9.7.1.0²,⁶.0⁸,¹⁹.0¹³,¹⁸]nonadeca-1(19),2(6),7,11,13(18),14,16-heptaen-9-one
5-(methylsulfanyl)-5-{[1-(methylsulfanyl)pent-4-en-1-yl]disulfanyl}pent-1-ene
4-amino-1,11-dihydroxy-10-methyl-3,6-dioxo-9-oxatricyclo[6.2.2.0²,⁷]dodeca-2(7),4-diene-5-carboximidic acid
(1r,5r,6s)-5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl 3-hydroxybenzoate
3-hydroxy-1-(4-methoxy-1-benzofuran-5-yl)-3-phenylprop-2-en-1-one
(2r,5r,6r)-11-bromo-2,5,6,10-tetramethyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(8),9,11-triene
C15H19BrO (294.06191839999997)
(3s,3's)-2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
2-[(2e)-2-(bromomethylidene)-1,3-dimethylcyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
4-bromo-1,5,12,12-tetramethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-triene
C15H19BrO (294.06191839999997)
(2s,3z,6z,9s,10r)-9-bromo-2-[(1z)-but-1-en-3-yn-1-yl]-10-ethyl-5,8,9,10-tetrahydro-2h-oxecine
C15H19BrO (294.06191839999997)
[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl (3s)-3,4-dihydroxy-2-methylidenebutanoate
4-(methylsulfanyl)-5-{pyrido[3,4-b]indol-9-ylmethyl}-3h-imidazole
(1r,9s,12s)-4-bromo-1,5,9,12-tetramethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-triene
C15H19BrO (294.06191839999997)
(3r,4r)-4-hydroxy-4-methyl-5-oxooxolan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
2-hydroxy-4,8-dimethyl-8h,9h-phenanthro[3,2-b]furan-7,11-dione
methyl 2-hydroxy-3-(8-hydroxy-6-methoxy-1-oxoisochromen-3-yl)propanoate
(3,4,5,6-tetrahydroxyoxan-2-yl)methyl 3,4-dihydroxy-2-methylidenebutanoate
(1r,9s,12r)-4-bromo-1,5,9,12-tetramethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-triene
C15H19BrO (294.06191839999997)
6,8-dihydroxy-7-(methoxycarbonyl)-5-methyl-1-oxoisochromene-3-carboxylic acid
2-[(1s,2e,3r)-2-(bromomethylidene)-1,3-dimethylcyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
4-bromo-5-methyl-2-(4,5,5-trimethylcyclopent-1-en-1-yl)phenol
C15H19BrO (294.06191839999997)
8-(1-chloro-2-hydroxy-3-methylbut-3-en-1-yl)-7-methoxychromen-2-one
(1s,9r,12s)-9-(bromomethyl)-1,5,12-trimethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene
C15H19BrO (294.06191839999997)
5-hydroxy-2-(3-hydroxyphenyl)furo[2,3-h]chromen-4-one
(2r,3r)-2,3-dihydroxy-2-phenyl-3h,5h-cyclopenta[c]isochromen-1-one
4-bromo-2-(1,2-dimethyl-3-methylidenecyclopentyl)-5-methylphenol
C15H19BrO (294.06191839999997)
5,6-dihydroxy-3-(hydroxymethyl)-2-oxocyclohex-3-en-1-yl 3-hydroxybenzoate
8,12-dihydroxy-7-methyl-3h,4h-phenanthro[2,1-c]pyran-1-one
4'-hydroxy-8h-spiro[acenaphthyleno[3,4-d][1,3]dioxole-1,1'-cyclohexan]-2'-en-2-one
4-({2-oxo-3h,3ah,4h,7ah-furo[2,3-b]pyran-4-yl}oxy)-3h,3ah,4h,7ah-furo[2,3-b]pyran-2-one
9-(bromomethylidene)-1,5,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)
(1r,4's)-4'-hydroxy-8h-spiro[acenaphthyleno[3,4-d][1,3]dioxole-1,1'-cyclohexan]-2'-en-2-one
2-[3-(bromomethylidene)-1,2-dimethylcyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
2-[(1r,2r,3z)-3-(bromomethylidene)-1,2-dimethylcyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
9-(bromomethylidene)-1,2,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)
5-[5-carboxy-4-(carboxymethyl)pyrrolidin-3-yl]pyridine-2-carboxylic acid
(2r,3s,4s)-4-hydroxy-2-methyl-5-oxooxolan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
3-acetyl-2-[(4-hydroxyphenyl)methyl]quinazolin-4-one
C17H14N2O3 (294.10043740000003)
2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
2-({2-[(2-carboxy-1-hydroxyethylidene)amino]-1-hydroxypropylidene}amino)benzoic acid
4-bromo-5-[(2r)-1,2-dimethylbicyclo[3.1.0]hexan-2-yl]-2-methylphenol
C15H19BrO (294.06191839999997)
4,8-dimethyl-3,4-dihydro-2,12-dioxatetraphene-1,5-dione
(6r)-9-(bromomethylidene)-1,5,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)
(3as,4r,7as)-4-{[(3as,4r,7as)-2-oxo-3h,3ah,4h,7ah-furo[2,3-b]pyran-4-yl]oxy}-3h,3ah,4h,7ah-furo[2,3-b]pyran-2-one
3-[(3s,4s,5s)-5-carboxy-4-(carboxymethyl)pyrrolidin-3-yl]pyridine-2-carboxylic acid
(3s)-3-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-4-methoxy-4-oxobutanoic acid
3-({[bis(methylsulfanyl)methylidene]amino}methylidene)-1-methoxyindol-2-one
C13H14N2O2S2 (294.04966640000004)
(3'r)-2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
(3r,3's)-2-hydroxy-4-methyl-3'-phenylspiro[1,4-benzodiazepine-3,2'-oxiran]-5-one
C17H14N2O3 (294.10043740000003)
(12r)-7-methoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-10-one
(4r)-4,8-dimethyl-3,4-dihydro-2,12-dioxatetraphene-1,5-dione
7-hydroxy-1-methyl-6-methylidene-7h,8h,9h-phenanthro[1,2-b]furan-10,11-dione
4-(4-hydroxyphenyl)-5-[(4-methoxyphenyl)methylidene]furan-2-one
7-methoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-10-one
[(2r,3s,4s,5r,6s)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl (3s)-3,4-dihydroxy-2-methylidenebutanoate
n-[2-(6-bromo-1h-indol-3-yl)ethyl]propanimidic acid
(1r,9s,12r)-9-(bromomethyl)-1,5,12-trimethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene
C15H19BrO (294.06191839999997)
(2s,5r,6r)-2-[(1s)-1-bromoethyl]-6-[(2e)-3-chloroprop-2-en-1-yl]-2,5-dimethyloxane
C12H20BrClO (294.03859600000004)
4-bromo-5-[(1s,2r,5r)-1,2-dimethylbicyclo[3.1.0]hexan-2-yl]-2-methylphenol
C15H19BrO (294.06191839999997)
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 3,4-dihydroxy-2-methylidenebutanoate
5-[(3s,4s,5s)-5-carboxy-4-(carboxymethyl)pyrrolidin-3-yl]pyridine-2-carboxylic acid
4-bromo-2-[(1r,2s)-1,2-dimethyl-3-methylidenecyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
(2r,5s,6s)-2-[(1r)-1-bromoethyl]-6-[(2e)-3-chloroprop-2-en-1-yl]-2,5-dimethyloxane
C12H20BrClO (294.03859600000004)
4-hydroxy-2-methyl-5-oxooxolan-3-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(3r)-3-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-4-methoxy-4-oxobutanoic acid
4-bromo-5-{1,2-dimethylbicyclo[3.1.0]hexan-2-yl}-2-methylphenol
C15H19BrO (294.06191839999997)
4-bromo-5-methyl-2-[(4r)-4,5,5-trimethylcyclopent-1-en-1-yl]phenol
C15H19BrO (294.06191839999997)
4-bromo-2-methyl-5-[(1r)-1,2,2-trimethylcyclopent-3-en-1-yl]phenol
C15H19BrO (294.06191839999997)
(3r)-3-{[3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-4-methoxy-4-oxobutanoic acid
(1r,3r,6r,7s,12r,13s,14s)-12-(hydroxymethyl)-2,4,9,11-tetraoxatricyclo[8.4.0.0³,⁷]tetradecane-6,7,13,14-tetrol
2-(1-bromoethyl)-6-(3-chloroprop-2-en-1-yl)-2,5-dimethyloxane
C12H20BrClO (294.03859600000004)
4-bromo-2-{1,2-dimethylbicyclo[3.1.0]hexan-2-yl}-5-methylphenol
C15H19BrO (294.06191839999997)
3-bromo-10-(but-1-en-3-yn-1-yl)-2-ethyl-3,4,7,10-tetrahydro-2h-oxecine
C15H19BrO (294.06191839999997)
(11r,12s)-11-methoxy-12-phenyl-5,13-dioxatricyclo[7.4.0.0²,⁶]trideca-1,3,6,8-tetraen-10-one
8-[(1r,2s)-1-chloro-2-hydroxy-3-methylbut-3-en-1-yl]-7-methoxychromen-2-one
6,13-dimethyl-15,18-dioxatetracyclo[8.8.0.0²,⁷.0¹²,¹⁶]octadeca-1(10),2(7),3,5,8,12(16)-hexaene-11,17-dione
(5s,6s,9z)-9-(bromomethylidene)-1,2,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)
(2s,3z,6z,9r)-9-[(1s)-1-bromopropyl]-2-[(1z)-but-1-en-3-yn-1-yl]-2,5,8,9-tetrahydrooxonine
C15H19BrO (294.06191839999997)
(5s,6s,9e)-9-(bromomethylidene)-1,2,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)
2-[(1s,2e,3s)-2-(bromomethylidene)-1,3-dimethylcyclopentyl]-5-methylphenol
C15H19BrO (294.06191839999997)
11-bromo-2,5,6,10-tetramethyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(8),9,11-triene
C15H19BrO (294.06191839999997)
2-[(1e)-2-methanesulfinylethenyl]-6,7-dimethoxychromen-4-one
C14H14O5S (294.05619140000005)
8-[(1r,2s)-2-chloro-1-hydroxy-3-methylbut-3-en-1-yl]-7-methoxychromen-2-one
(6r,9z)-9-(bromomethylidene)-1,5,5-trimethylspiro[5.5]undeca-1,7-dien-3-one
C15H19BrO (294.06191839999997)